STOK

Stoke Therapeutics Stock Analysis

AI Rating

Fair
  • Quality3/10
  • Growth↑ 8/10
  • Value↓ 0/10
Stoke Therapeutics sales and earnings growth
STOK Growth
Good
  • Revenue Y/Y↑ 404.50%
  • EPS Y/Y↑ 92.73%
  • FCF Y/Y↑ 151.59%
Stoke Therapeutics gross and profit margin trends
STOK Profitability
Good
  • Gross margin ↑ 100.00%
  • EPS margin↓ -3.70%
  • ROIC 5Y↓ -198.45%
Stoke Therapeutics net debt vs free cash flow
STOK Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1.5

Stoke Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗